A California jury found Monsanto liable in a lawsuit filed by a man who alleged the company’s glyphosate-based weed-killers, including Roundup, caused him cancer and ordered the company to pay USD 289 million in damages.
The case of school groundskeeper Dewayne Johnson was the first lawsuit alleging glyphosate causes cancer to go to trial. Monsanto, a unit of Bayer AG following a USD 62.5 billion acquisition by the German conglomerate, faces more than 5,000 similar lawsuits across the United States.
The jury at San Francisco’s Superior Court of California deliberated for three days before finding that Monsanto had failed to warn Johnson and other consumers of the cancer risks posed by its weed killers and it It awarded USD 39 million in compensatory and USD 250 million in punitive damages.
Monsanto said in a statement that it would appeal the verdict.
DeWayne Johnson’s case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin’s lymphoma, a cancer of the lymph system that he alleges was caused by Roundup and Ranger Pro, another Monsanto glyphosate herbicide.
Monsanto denies that glyphosate, the world’s most widely used herbicide, causes cancer and says decades of scientific studies have shown the chemical to be safe for human use.
A former pest control manager for a California county school system, Johnson, 46, applied the weed killer up to 30 times per year.
Brent Wisner, a lawyer of Dewayne Johnson, said in a statement to the jurors that he had seen internal company documents ”proving that Monsanto has known for decades that glyphosate and specifically Roundup could cause cancer.”
The U.S. Environmental Protection Agency in September 2017 concluded a decades-long assessment of glyphosate risks and found the chemical not likely carcinogenic to humans. But the World Health Organization’s cancer arm in 2015 classified glyphosate as ”probably carcinogenic to humans.”
The post Monsanto ordered to pay USD 289 million in lawsuit over cancer claims appeared first on Business Review.